Assignee
SCRIPTGEN PHARM INC
US·20 granted patents·583 citations·filing 1994–2000
Top patents by PatentIndex Score
20 records- 0195US5585277AScreening method for identifying ligands for target proteinsSCRIPTGEN PHARM INC·Filed 1995·Granted Dec 17, 1996·233 cites·17 claims
- 0292US5679582AScreening method for identifying ligands for target proteinsSCRIPTGEN PHARM INC·Filed 1994·Granted Oct 21, 1997·141 cites·47 claims
- 0380US6020488ASmall molecule inhibition of RNA/ligand bindingSCRIPTGEN PHARM INC·Filed 1997·Granted Feb 1, 2000·20 cites·6 claims
- 0479US6140361AUse of 2-deoxystreptamine as a molecular scaffold for the preparation of functionally and spatially diverse molecules and pharmaceutical compositions thereofSCRIPTGEN PHARM INC·Filed 1999·Granted Oct 31, 2000·18 cites·8 claims
- 0575US6022983APyronin antibacterials, process and novel intermediates theretoSCRIPTGEN PHARM INC·Filed 1998·Granted Feb 8, 2000·15 cites·15 claims
- 0673US5942547A2-Deoxystreptamine derivatives, pharmaceutical compositions thereof and therapeutic methods using sameSCRIPTGEN PHARM INC·Filed 1996·Granted Aug 24, 1999·17 cites·7 claims
- 0772US6335339B1Triazine antiviral compoundsSCRIPTGEN PHARM INC·Filed 1999·Granted Jan 1, 2002·48 cites·14 claims
- 0865US6239291B1Pyronin antibacterials, process and novel intermediates theretoSCRIPTGEN PHARM INC·Filed 2000·Granted May 29, 2001·2 cites·2 claims
- 0960US6004779ARegulated gene expression in yeastSCRIPTGEN PHARM INC·Filed 1998·Granted Dec 21, 1999·12 cites·18 claims
- 1060US5668165ASmall molecule inhibition of RNA/ligand bindingSCRIPTGEN PHARM INC·Filed 1995·Granted Sep 16, 1997·14 cites·36 claims
- 1149US6051373AMethods for screening for inhibitors of the transcription-enhancing activity of the X protein of hepatitis B virusSCRIPTGEN PHARM INC·Filed 1994·Granted Apr 18, 2000·13 cites·10 claims
- 1247US6165998AAntifungal agentsSCRIPTGEN PHARM INC·Filed 1998·Granted Dec 26, 2000·10 cites·7 claims
- 1345US6337183B1Screen for compounds with affinity for nucleic acidsSCRIPTGEN PHARM INC·Filed 1996·Granted Jan 8, 2002·5 cites·19 claims
- 1444US5760063AArylhydrazone derivatives useful as antibacterial agentsSCRIPTGEN PHARM INC·Filed 1996·Granted Jun 2, 1998·25 cites·19 claims
- 1542US5863762ANucleic acids encoding TFIIB transcription factor from candida albicansSCRIPTGEN PHARM INC·Filed 1996·Granted Jan 26, 1999·7 cites·4 claims
- 1639US6300067B1TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growthSCRIPTGEN PHARM INC·Filed 1998·Granted Oct 9, 2001·2 cites·9 claims
- 1734US6090953APyronin antibacterials, process and novel intermediates theretoSCRIPTGEN PHARM INC·Filed 1999·Granted Jul 18, 2000·0 cites·8 claims
- 1832US6194399B1Aryldiamine derivatives useful as antibacterial agentsSCRIPTGEN PHARM INC·Filed 1999·Granted Feb 27, 2001·1 cites·6 claims
- 1931US6127551APyronin antibacterials, process and novel intermediates theretoSCRIPTGEN PHARM INC·Filed 1999·Granted Oct 3, 2000·0 cites·8 claims
- 2029US5986111APyronin antibacterials, process and novel intermediates theretoSCRIPTGEN PHARM INC·Filed 1997·Granted Nov 16, 1999·0 cites·26 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →